Se requiere una suscripción a JoVE para ver este contenido. Inicie sesión o comience su prueba gratuita.
The protocol summarizes the best practices to minimize microbial bioburden in a cleanroom environment and includes strategies such as environmental monitoring, process monitoring, and product sterility testing. It is relevant for manufacturing and testing facilities that are required to meet current good tissue practice standards and current good manufacturing practice standards.
A well-validated and holistic program that incorporates robust gowning, cleaning, environmental monitoring, and personnel monitoring measures is critical for minimizing the microbial bioburden in cellular therapy manufacturing suites and the corresponding testing laboratories to ensure that the facilities are operating in a state of control. Ensuring product safety via quality control measures, such as sterility testing, is a regulatory requirement for both minimally manipulated (section 361) and more than minimally manipulated (section 351) human cells, tissues, and cellular and tissue-based products (HCT/Ps). In this video, we provide a stepwise guide for how to develop and incorporate the best aseptic practices for operating in a cleanroom environment, including gowning, cleaning, staging of materials, environmental monitoring, process monitoring, and product sterility testing using direct inoculation, provided by the United States Pharmacopeia (USP<71>) and the National Institutes of Health (NIH) Alternative Sterility Testing Method. This protocol is intended as a reference guide for establishments expected to meet current good tissue practices (cGTP) and current good manufacturing practices (cGMP).
Implementing a strong microbial monitoring program through environmental monitoring (EM), process monitoring, and product sterility testing is a regulatory requirement for current good tissue practices (cGTP) and current good manufacturing practices (cGMP) in cellular therapy laboratories1. Additionally, the United States Food and Drug Administration (FDA) expects that the laboratory performing the quality control (QC) testing of the product should also employ facilities and controls comparable to those used for aseptic filling operations2.
This protocol has four main sections: 1) Aseptic pra....
1. Aseptic practices
The expected results are described in Table 1. The EM data should be reviewed and followed up with an appropriate investigation and response to action, alert, or ISO limit excursions. If an excursion occurs for non-viable particles, one should proceed as per ISO 14644-Annex A, sec A.5.57. If the excursion can be attributed to an immediately identifiable abnormal occurrence, the original sampling results should be documented, a note should be added to disregard the original results.......
There are several critical areas in this protocol, including the maintenance of aseptic technique and unidirectional airflow within cleanrooms and the BSCs. Best practices include moving slowly and deliberately to minimize turbulence. Aseptic manipulations should be performed from the side of the product, not from above. Closed system processing and the use of terminally sterilized raw materials are recommended. Speaking in critical areas and leaning against walls or equipment should be avoided. Similarly, unnecessary to.......
This work was supported by the Intramural Research Program of the National Institutes of Health Clinical Center. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.
....Name | Company | Catalog Number | Comments |
20-25°C Incubator | Lab preference | ||
30-35°C Incubator | Lab preference | ||
Alcohol-based hand sanitizer | Lab preference | ||
BacT/ALERT Dual-T instrument | BioMerieux Industry | ||
Beard cover | Lab preference | ||
Biosafety cabinet (BSC) | Lab preference | ||
Cleanroom shoes | Lab preference | ||
Fluidthioglycollate medium (FTM) | Hardy Diagnostics | U84 | USP |
Handheld cleaning mop | Contec | 2665LF | |
Hypodermic needle | Lab preference | ||
iFA+ BacT/ALERT bottle | Biomerieux | 412990 | |
iFN+ BacT/ALERT bottle | Biomerieux | 412991 | |
Isokinetic head | Lab preference | ||
Laser particle counter | TSI Incorporated | 9500-01 | |
LpH III | Steris | 1S16CX | |
Mirror | Lab preference | ||
Non-sterile bouffant | Lab preference | ||
Non-sterile gloves | Lab preference | ||
Non-sterile shoe covers | Lab preference | ||
Non-sterile sleeve covers | Lab preference | ||
Parafilm | Lab preference | ||
Peridox RTU | Contec | CR85335IR | |
Plastic bag | Lab preference | ||
Sabouraud Dextrose Agar with Lecithinase and Tween (SABLT) | Hardy Diagnostics | P595 | USP, irradiated |
Sabouraurd Dextrose Agar (SAB) | Hardy Diagnostics | W565 | USP, irradiated |
Safety glasses | Lab preference | ||
Scrubs (top and bottom) | Lab preference | ||
Spor-Klenx RTU | Steris | 6525M2 | |
Sterile 70% isopropyl alcohol (IPA) | Decon CiDehol | 8316 | |
Sterile alcohol wipe | Lab preference | ||
Sterile boot covers | Kimberly Clark | Cat# varies based on size | |
Sterile coveralls | Kimberly Clark | Cat# varies based on size | |
Sterile face mask | Lab preference | ||
Sterile gloves | Lab preference | ||
Sterile hood | Kimberly Clark | Cat# varies based on size | |
Sterile low-lint wipes | Texwipe | TX3210 | |
Sterile mop cleaning pads | Contec | MEQT0002SZ | |
Sterile sleeve covers | Kimberly Clark | 36077 | |
Sterile spreading rod | Fisher Scientific | 14665231 | |
Sterile syringe | Lab preference | ||
Tacky mats | Lab preference | ||
Tryptic Soy Agar (TSA) | Hardy Diagnostics | W570R | USP, irradiated |
Tryptic Soy Agar with Lecithinase and Tween (TSALT) | Hardy Diagnostics | P520R | USP, irradiated |
Tryptic Soy Broth (TSB) | Hardy Diagnostics | U46 | USP |
Tubing | Lab preference | ||
Vesphene III | Steris | 1S15CX | |
Viable air sampler | Hardy Diagnostics | BAS22K | |
Vortex | Lab preference |
Explore More Articles
This article has been published
Video Coming Soon
ACERCA DE JoVE
Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados